Company Long-Term Loans and Borrowings: Electromed, Inc. (ELMD)
High patent barriers and strict FDA oversight provide Electromed, Inc. (ELMD) with a sustainable position, bolstered by physician loyalty and dominance in the home therapy segment. This price chart illustrating value trends serves as an indicator of long-term debts, which currently stand at 0.00. Electromed, Inc. (ELMD) generates revenue through the sale of SmartVest systems for patients with COPD and cystic fibrosis via insurance reimbursements.
Electromed - analytical breakdowns and key metrics (ELMD)
Long-term debt measures the total liabilities with a maturity exceeding one year, determining the balance between investment development and financial stability. For Electromed, Inc. (ELMD), such loans may finance the expansion of SmartVest portable systems, supporting a steady flow of insurance payments. An analysis of the firm's long-term borrowed funds allows for an assessment of whether the credit load exceeds the business's capabilities. An optimal debt level confirms fundamental reliability and the potential for share price growth.